Cleveland biotech company Western Oncolytics is developing an immune-oncolytic therapy licensed by the University of Pittsburgh which combines oncolytic virus and gene therapy technologies to rid cancer cells of the ability to survive in the body. According to their website, the company expects their technology to extend the lives of, or even cure, patients with an array of […]
With a little genetic engineering, the vaccine that was key in helping eradicate smallpox more than 30 years ago could also be key in curing cancer, if a young Cleveland biotech has anything to say about it. Western Oncolytics is developing a dual-mechanism therapy that combines oncolytic virus and gene therapy technologies with the hope […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
An academia-industry partnership between Ohio State University and biopharmaceutical company MedVax Technologies will take a new vaccine aimed at preventing and treating certain kinds of cancers through clinical development. The vaccine, developed by Ohio State researchers, targets cancers associated with the HER2 protein, which is thought to play a role not only in breast cancer […]
Roche’s move to skip over Inovio’s (NYSE: INO) late stage drugs for cervical cancer and Hepatitis C and make a beeline for its preclinical DNA vaccines for prostate cancer and Hep B was initially a little puzzling. Investors have preferred to park their money further upstream when products are in the clinic and they’ve been […]